201 related articles for article (PubMed ID: 8539539)
21. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998.
Thierfelder W; Hellenbrand W; Meisel H; Schreier E; Dortschy R
Eur J Epidemiol; 2001; 17(5):429-35. PubMed ID: 11855576
[TBL] [Abstract][Full Text] [Related]
22. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal.
Sawayama Y; Hayashi J; Ariyama I; Furusyo N; Kawasaki T; Kawasaki M; Itoh K; Acharya GP; Kashiwagi S
J Epidemiol; 1999 Nov; 9(5):350-4. PubMed ID: 10616269
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Saillour F; Dabis F; Dupon M; Lacoste D; Trimoulet P; Rispal P; Monlun E; Ragnaud JM; Morlat P; Pellegrin JL; Fleury H; Couzigou P
BMJ; 1996 Aug; 313(7055):461-4. PubMed ID: 8776313
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and molecular analysis of hepatitis A, B and C in a semi-urban and rural area of Crete.
Drositis I; Bertsias A; Lionis C; Kouroumalis E
Eur J Intern Med; 2013 Dec; 24(8):839-45. PubMed ID: 23988264
[TBL] [Abstract][Full Text] [Related]
26. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
[TBL] [Abstract][Full Text] [Related]
27. [Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain].
Cifuentes C; Mira JA; Vargas J; Neukam K; Escassi C; García-Rey S; Gilabert I; González-Monclova M; Bernal S; Pineda JA
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):452-7. PubMed ID: 22541340
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of hepatitis B virus and hepatitis C virus in Monte Negro in the Brazilian western Amazon region.
El Khouri M; Duarte LS; Ribeiro RB; da Silva LF; Camargo LM; dos Santos VA; Burattini MN; Corbett CE
Clinics (Sao Paulo); 2005 Feb; 60(1):29-36. PubMed ID: 15838578
[TBL] [Abstract][Full Text] [Related]
29. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
30. [The prevalence of antibodies directed against hepatitis C virus in hepatocellular carcinoma: relation to hepatitis B virus, Pugh's score, Okuda's staging and survival].
Giovannini M; Seitz JF; Pingannaud MP; Sauvan R; Rossi I; Pasquier J; Gauthier A
Ann Gastroenterol Hepatol (Paris); 1991; 27(1):36. PubMed ID: 1851405
[No Abstract] [Full Text] [Related]
31. [Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975-89].
Kielland KB; Siebke JC
Tidsskr Nor Laegeforen; 1991 Mar; 111(7):821-4. PubMed ID: 1902331
[TBL] [Abstract][Full Text] [Related]
32. Concomitant high prevalence of hepatitis C virus antibodies and hepatitis B virus markers in a small village of the Amazon Region, Mato Grosso State, Brazil.
Souto FJ; Fontes CJ; Gaspar AM; Paraná R; Lyra LG
Rev Inst Med Trop Sao Paulo; 1996; 38(3):221-3. PubMed ID: 9163988
[No Abstract] [Full Text] [Related]
33. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
Goeser T; Theilmann L
Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
[No Abstract] [Full Text] [Related]
34. Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran.
Zahedi MJ; Moghaddam SD; Abasi MH; Parnian M; Shokoohi M
J Pak Med Assoc; 2014 Feb; 64(2):134-7. PubMed ID: 24640799
[TBL] [Abstract][Full Text] [Related]
35. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination.
Fujiyama S; Odoh K; Kuramoto I; Mizuno K; Tsurusaki R; Sato T
J Hepatol; 1994 Oct; 21(4):641-5. PubMed ID: 7814811
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of antibodies to hepatitis A and B viruses in Port Chalmers residents.
Austin FJ; Maguire T; Jennings LC; MacDiarmid RD
N Z Med J; 1982 Feb; 95(701):72-3. PubMed ID: 6281700
[No Abstract] [Full Text] [Related]
37. [Prevalence of anti-HAV antibodies in Warsaw population].
Janaszek-Seydlitz W; Bucholc B; Wiatrzyk A
Przegl Epidemiol; 2007; 61(4):675-82. PubMed ID: 18572499
[TBL] [Abstract][Full Text] [Related]
38. [Superinfection of hepatitis viruses].
Chen Z; Liu X; Li LY
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Oct; 15(5):275-7. PubMed ID: 7532107
[TBL] [Abstract][Full Text] [Related]
39. [Practical remarks regarding the analysis of markers of acute viral hepatitis].
Oszczak A; Maciejewska E
Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):283-4. PubMed ID: 1332002
[No Abstract] [Full Text] [Related]
40. Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses.
Vardas E; Ross MH; Sharp G; McAnerney J; Sim J
J Hosp Infect; 2002 Jan; 50(1):6-12. PubMed ID: 11825045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
